Vardhaman Laboratories (Delisted) financials and balance sheet

BSE: 524796Pharmaceuticals & Biotechnology

Last traded ₹0.51 on 16 Aug 2019

Delisted on 13 Jul 2022.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Vardhaman Laboratories annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹1.22 Cr, year to Mar 2011A loss in 7 of the 8 years with results on record

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2018

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Other income0.0
  3. Profit before tax0.0
  4. Net profit0.0

Profit and loss

Standalone, ₹ crore, years to March. No results on record for the years to Mar 2009 and Mar 2015.Vardhaman Laboratories quarterly results

₹ croreMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue from operations0.271.220.53––––0.040.04
0.441.15–––––––
Materials and goods bought–1.010.51––––––
Employee costs–0.10–––––––
Other expenses–0.11–––––––
Operating profit before depreciation−0.160.06–––––––
Operating margin−60.6%5.0%–––––––
Materials, % of revenue–83.1%–––––––
Employee costs, % of revenue–8.3%–––––––
Other expenses, % of revenue–9.1%–––––––
Depreciation and amortisation0.080.08–––––––
Operating profit after depreciation−0.24−0.02–––––––
Other income0.020.030.060.010.02–0.050.040.04
Finance costs0.000.08–––––––
Profit before tax−0.23−0.14−0.02−0.02−0.02–−0.03−0.04−0.04
Tax–––0.06–––––
Net profit−0.23−0.140.27−0.10−0.02–−0.03−0.04−0.04
Net margin−86.3%−11.2%51.5%––––−100.0%−105.7%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2010 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2012, Mar 2017 and Mar 2018: the statement does not state its finance costs or depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2013, Mar 2014 and Mar 2016: the statement does not state its revenue, finance costs or depreciation, which operating profit is worked out from, so operating profit is not given.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Earnings per share₹0.66−₹0.23−₹0.05–−₹0.08−₹0.09−₹0.09
Diluted earnings per share₹0.66−₹0.23−₹0.05–−₹0.08−₹0.09−₹0.09
Market cap at the year end (₹ crore)1.761.57––0.48––

Ratios

Standalone, years to March.

RatioMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue growth348.3%−56.2%–––––−5.4%
Interest cover is left blank for the years to Mar 2010 and Mar 2011: operating profit after depreciation is a loss, and a loss covers no interest bill.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2018.

Measure10 years5 years3 years
Revenue growth, yearly rate−23.3%––
Net margin, average––−102.9%